GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is now available at a cash price of $149 per ...
GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced a new collaboration with ...
Latest CPPI Data Shows Personal Drug Importation from Canada Provides More Affordable Medication Access; Could Prevent ...
Consumers can soon go to GoodRx (GDRX) for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation “We’re excited to help consumers access one of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results